Minutes of the ICMAD Board of Directors Meeting March 12, 2015 held at the Locke Lord LLP Offices, 750 Lexington Avenue, New York, New York. Attending: Robb Akridge, Joe Atencio, Michael Benjamin, Sharon Blinkoff, Pam Busiek, , Carl Geffken, Ian Ginsberg, Jane Iredale( by phone), Stan Katz, Debra Lippmann , Joe Mastalia, Colleen Pierce, Ada Polla, Mary Ptak, David Steinberg, Lisa Thurman, Pam Viglielmo, Craig Weiss, JuE Wong, Bill Zrebiec. Ken Hegel ( guest) Robert Harmala as a guest Rob Akridge, as Chairman, called the meeting to order and made his opening remarks, as part of his opening remarks he reviewed the ICMAD mission statement. Rob then presented the Consent Agenda and requested that a motion be made to pass a resolution approving the consent Agenda. A motion was so made, seconded and unanimously passed to adopt the following Resolution: Resolution: Be it Resolved that the Consent Agenda presented to the Board of Directors accepting the Minutes of the January 8th, 2015 Board of Directors meeting, the Treasurers Report, and the New Members submitted with the Consent Agenda be approved. The Presidents report was presented as submitted in the Board Package. Pam Busiek and Robert Harmala ICMAD’s Legislative Counsel presented on the State of the proposed Cosmetic legislation which was currently in Senator Feinstein office and which would be introduced by the Senator when she got bipartisan support. The status of the Feinstein bill and its provisions were discussed. Pam reviewed the history of the developments that led from the nearly year long meetings with the FDA and PCPC that led to Senator Feinstein taking charge of the bill. Pam reviewed the positions of the three trade associations and why ICMAD was going to have to break from the PCPC positions’ based upon what was in the proposed bill. Robert Harmala reviewed the state of affairs in Washington from a legislative perspective and then specifically reviewed the strategy for dealing with the Feinstein situation and the opportunities for ICMAD and the development of relationships with the Republican leaders who were sympathetic to the needs of small business. Robert Harmala outlined several potential strategies and discussed the groundwork that had been set with Chairman Upton and his staff and their receptivity to an ICMAD sponsored bill that would be fashioned on the original Lance Bill and that would focus on Preemption and support for small business. Considerable discussion followed these presentations and the Board unanimously endorsed continuing the course outlined by Pam and Robert Harmala to countering the Feinstein initiative and proceeding with ICMAD sponsored legislation. Sharon Blinkoff, Chair of the Government Relations Committee reported on recent FDA activity and announced that Michael Lunceford of Mary Kay was joining the Govnerment relations committee. Carl Gefkin presented the International Committee report as submitted in the Board Package. Joe Mastalia and Bill Zreibec co-chairs of the Membership Committee presented the Membership committee report. Technical Regulatory Committee Craig Weiss, the Chair of the committee outlined the activities of his committee that were included in the Board Package. No new business items were raised and the Formal Meeting was adjourned by Robb Akridge as the Chairman. Respectfully submitted, Sharon Blinkoff, Secretary